In 2013, only 14% of male adolescents completed the full vaccination series of three doses.
As of 2011, the human papilloma virus (HPV) vaccine is recommended for male adolescents in the U.S. So, how many are actually receiving it?
To answer this question, investigators analyzed data on 9554 male adolescents aged 13 to 17 years collected from a 2013 national random-digit-dial household telephone survey. A parent or guardian completed the household telephone interview and was asked for consent to contact their child's provider for immunization records. The majority of adolescents were non-Hispanic white (54%), were living above 133% of the federal poverty level (66%), and had one physician contact in the last year (82%). Results were as follows:
Reviewing Author
DisclosuresGrant/Research SupportNIH Institutional Clinical and Translational Science Award; Agency for Healthcare Research and Quality National Center for Pediatric Practice Based Research Learning; Patient-Centered Outcomes Research Institute
Editorial BoardsCurrent Problems in Pediatric Adolescent Healthcare
Leadership Positions in Professional Societies College of Physicians of Philadelphia (Board of Trustees)
DisclosuresGrant/Research SupportNIH Institutional Clinical and Translational Science Award; Agency for Healthcare Research and Quality National Center for Pediatric Practice Based Research Learning; Patient-Centered Outcomes Research Institute
Editorial BoardsCurrent Problems in Pediatric Adolescent Healthcare
Leadership Positions in Professional Societies College of Physicians of Philadelphia (Board of Trustees)